Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2019 Jul 10;28(10):1735–1745. doi: 10.1158/1055-9965.EPI-19-0066

Table 1. MCF-7 BCa Risk Enhancers.

Listed are the 10 best BCa risk loci in MCF-7 and the corresponding 10 MCF-7 risk enhancers which are most suitable for follow up testing. Each enhancer overlaps the most significant GWAS SNP at the locus, and the locus shows both an enrichment greater than 2 (frequency of BCa credible risk variants (CRVs) overlapping enhancers compared to background overlap frequency), as well as a proportion of the CRV risk span that overlaps enhancers greater than more than 95% background overlap proportions. The enrichment and overlap values may be modified by overlap of risk SNPs with other enhancers at the same locus. The overall GWAS significance, ER+ GWAS significance, and reported genes from Michailidou et. al. are listed. Additionally, all but the enhancer at locus 19 are unique to MCF-7 and do not overlap HMEC enhancers locations, so the differentially expressed genes (relative to HMEC) within 500 Kb or 1 MB of each lead SNP are identified as putative risk genes in MCF-7.

Locus Alt. Locus ID CRVs Enh. Overlap CRVs in Locus Hyper. P.Val. (−log) Ratio Enrich. Span Overlap Signif. (−log) Lead SNP ID Comb. GWAS P.Val. Comb. GWAS P. Val., ER Risk Enhancer Start Risk Enhancer Stop Gene MCF-7 DE Genes 0–500Kb MCF-7 DE Genes 500Kb −1Mb
1p36.22 1_10566215 8 50 4.29 5.79 1.72 rs2506889 2.38E-20 1.10E-07 10595877 10599012 PEX14 APITD1, TARDBP, UBE4B, PEX14 SRM, SLC25A33, PIK3CD, LZIC, PTCHD2, CLSTN1, EXOSC10, MTOR
3p26.1 3_4742276 1 22 0.65 3.31 1.71 rs6787391 9.07E-19 1.20E-15 4727872 4732087 EGOT, ITPR1 BHLHE40, ARL8B, ITPR1, EDEM1
6q25 6_151952332 10 10 12.50 17.64 2.19 rs60954078 2.84E-54 1.70E-22 151948050 151959756 ESR1 ZBTB2, RMND1, AKAP12, C6orf211, SYNE1, ESR1 MTHFD1L, PLEKHG1
8q22.3 8_102478959 2 8 1.50 6.62 1.66 rs514192 5.61E-09 9.90E-09 102478133 102481107 YWHAZ, GRHL2, KLF10 ZNF706, GRHL2 ANKRD46, YWHAZ, RRM2B, UBR5, PABPC1
10p14 10_9088113 30 42 23.50 8.93 2.15 rs60954078 1.73E-10 6.00E-08 9074392 9089320 GATA3 NA GATA3
12q24.31 12_120832146 2 26 0.80 2.32 1.54 rs206966 3.79E-08 1.40E-06 120831824 120833249 DYNLL1, GATC TRIAP1, SRSF9, POP5, PXN, MSI1, DYNLL1, COQ5, UNC119B, CCDC64, RNF10 PRKAB1, P2RX4, CIT, ANAPC5
16q23.2 16_80650805 8 17 9.69 26.12 2.66 rs7500067 4.06E-27 2.90E-21 80647147 80651103 CDYL2 ATMIN, CENPN, CDYL2 GAN, CMIP
17q25.3 17_77781725 3 13 2.56 9.98 1.90 rs8082452 1.14E-10 2.40E-06 77769769 77772332 NA CBX2, CBX8, CBX4, CARD14, SGSH, SLC26A11, TBC1D16, EIF4A3 TIMP2, LGALS3BP, ENDOV, USP36, RPTOR
19pl3.12 19_13954571 19 43 13.35 8.74 2.74 rs2594714 1.08E-08 1.70E-05 13948902 13955856 JUNB, NANOS3 MIR24–2, PALM3, SAMD1, CCDC130, ZSWIM4, C19orf57, PODNL1, ASF1B, CALR, SYCE2, TRMT1, CD97, GIPC1, DNAJB1, HOOK2, MAST1,
21q21.1 21_16520832 2 2 4.32 143.22 2.52 rs2403907 1.87E-32 4.20E-23 16570278 16574820 NRIP1 NRIP1 HSPA13, USP25